Randomized Trial Comparing the Effect of Endometrial Shedding With Medroxyprogesterone Acetate With Random Start of Clomiphene Citrate for Ovulation Induction in Oligo-ovulatory and Anovulatory Women

Journal of Obstetrics and Gynaecology Canada

Volumn 38, Issue 5, 2016, Pages 458-464

  Jones, Claire Ann ^a,b   Garbedian, Kimberly ^c   Dixon, Marjorie ^b,d   Murphy, Kellie ^a,b   Shapiro, Heather ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Hannam Fertility Centre   (Canada)

^d First Steps Fertility   (Canada)

Author keywords

clomiphene; infertility; medroxyprogesterone acetate; ovulation induction; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; MEDROXYPROGESTERONE ACETATE; CLOMIFENE;

ADULT; AMENORRHEA; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIAL SHEDDING; ENDOMETRIAL THICKNESS; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FEMALE INFERTILITY; HUMAN; MENSTRUATION; OLIGOMENORRHEA; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT DURATION; WOMEN'S HEALTH; DRUG EFFECTS; ENDOMETRIUM; PREGNANCY; PROCEDURES; YOUNG ADULT;

ADULT; ANOVULATION; CLOMIPHENE; ENDOMETRIUM; FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; OVULATION INDUCTION; PREGNANCY; YOUNG ADULT;

EID: 84978986039     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2016.01.009     Document Type: Article

References (26)

1. 1 Hull, M.G., Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1 (1987), 235–245.
2. 2 Imani, B., Eijkemans, M.J., te Velde, E.R., Habbema, J.D., Fauser, B.C., Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84 (1999), 1617–1622.
3. 3 Balen, A.H., Braat, D.D., West, C., Patel, A., Jacobs, H.S., Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients. Hum Reprod 9 (1994), 1563–1570.
4. 4 Legro, R.S., Barnhart, H.X., Schlaff, W.D., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 356 (2007), 551–566.
5. 5 Legro, R.S., Zhang, H., Eunice Kennedy Shriver NICHD Reproductive Medicine Network. Letrozole or clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 371 (2014), 1463–1464.
6. 6 Zain, M.M., Jamaluddin, R., Ibrahim, A., Norman, R.J., Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril 91 (2009), 514–521.
7. 7 Von Hofe, J., Bates, G.W., Ovulation induction. Obstet Gynecol Clin North Am 42 (2015), 27–37.
8. 8 Young, S.L., Opsahl, M.S., Fritz, M.A., Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women. Fertil Steril 71 (1999), 639–644.
9. 9 Gonen, Y., Casper, R.F., Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 5 (1990), 670–674.
10. 10 Dickey, R.P., Olar, T.T., Taylor, S.N., Curole, D.N., Matulich, E.M., Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin. Fertil Steril 59 (1993), 756–760.
11. 11 Fanchin, R., Righini, C., Ayoubi, J.M., Olivennes, F., de Ziegler, D., Frydman, R., New look at endometrial echogenicity: objective computer-assisted measurements predict endometrial receptivity in in vitro fertilization-embryo transfer. Fertil Steril 74 (2000), 274–281.
12. 12 Palomba, S., Russo, T., Orio, F. Jr., Falbo, A., Manguso, F., Sammartino, A., et al. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod 21 (2006), 2823–2829.
13. 13 Badawy, A., Inany, H., Mosbah, A., Abulatta, M., Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a novel protocol. Fertil Steril 91 (2009), 838–841.
14. 14 Eden, J.A., Place, J., Carter, G.D., Jones, J., Alaghband-Zadeh, J., Pawson, M.E., The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynecol 73 (1989), 187–190.
15. 15 Randall, J.M., Templeton, A., Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles. Fertil Steril 56 (1991), 208–212.
16. 16 Haritha, S., Rajagopalan, G., Follicular growth, endometrial thickness, and serum estradiol levels in spontaneous and clomiphene citrate-induced cycles. Int J Gynaecol Obstet 81 (2003), 287–292.
17. 17 Diamond, M.P., Kruger, M., Santoro, N., Zhang, H., Casson, P., Schlaff, W., et al. Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol 119 (2012), 902–908.
18. 18 Fritz, M.A., Speroff, M.A., Clinical gynecologic endocrinology and infertility, ed 8. 2011, Lippincott Williams & Wilkins, Philadelphia, PA.
19. 19 Hurst, B.S., Hickman, J.M., Matthews, M.L., Usadi, R.S., Marshburn, P.B., Novel clomiphene “stair-step” protocol reduces time to ovulation in women with polycystic ovarian syndrome. Am J Obstet Gynecol 200 (2009), 510.e1–510.e4.
20. 20 Budinetz, T.H., Benadiva, C.A., Griffin, D.W., Engmann, L.L., Nulsen, J.C., DiLuigi, A.J., Ovulation rate and cycle characteristics in a subsequent clomiphene citrate cycle after stair-step protocol. Fertil Steril 103 (2015), 675–679.
21. 21 Deveci, C.D., Demir, B., Sengul, O., Dilbaz, B., Goktolga, U., Clomiphene citrate ‘stair-step’ protocol vs. traditional protocol in patients with polycystic ovary syndrome: a randomized controlled trial. Arch Gynecol Obstet 291 (2015), 179–184.
22. 22 Sirmans, S.M., Pate, K.A., Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 6 (2013), 1–13.
23. 23 Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril 89 (2008), 505–522.
24. 24 Casper, R.F., Detrimental effect of induced or spontaneous menses before ovulation induction on pregnancy outcome in patients with polycystic ovary syndrome. Obstet Gynecol 119 (2012), 886–887.
25. 25 Kuang, Y., Chen, Q., Fu, Y., Wang, Y., Hong, Q., Lyu, Q., et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 104 (2015), 62–70.e3.
26. 26 Valdez-Morales, F.J., Gamboa-Dominguez, A., Vital-Reyes, V.S., Cruz, J.C., Chimal-Monroy, J., Franco-Murillo, Y., et al. Changes in receptivity epithelial cell markers of endometrium after ovarian stimulation treatments: its role during implantation window. Reprod Health, 12, 2015, 45.